Legal Opinion
Allergan, Inc. v. Crawford
District Court, District of Columbia
Decided January 19, 2005No. CIV.A. 03-2236RMCPublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION
COLLYER, District Judge.
This lawsuit arises from a dispute over the Food and Drug Administration’s (“FDA”) classification of cyclosporine as an “antibiotic” drug. Allergan, Inc. (“Aller-gan”) is a pharmaceutical company that manufactures Restasis®, a 0.05% topical ophthalmic emulsion of cyclosporine that is used to treat an eye condition known as keratoconjunctivitis or dry eye disease. Allergan argues that cyclosporine is not an “antibiotic” drug because the substance actually suppresses the human body’s immune system, making the patient more and not less susceptible to…
2Cases cited28 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- Skidmore v. Swift & Co.Supreme Court of the United States · 1944
- Securities & Exchange Commission v. Chenery Corp.Supreme Court of the United States · 1947
23 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Viropharma Incorporated v. HamburgDistrict Court, District of Columbia · 2012
- Astrazeneca Pharmaceuticals Lp v. Food and Drug AdministrationDistrict Court, District of Columbia · 2012
- Veloxis Pharmaceuticals, Inc. v. United States Food and Drug AdministrationDistrict Court, District of Columbia · 2015
- In re Viropharma Inc. Securities LitigationDistrict Court, E.D. Pennsylvania · 2014
- Cogent Healthcare of Arizona PC v. Blue Cross and Blue Shield of Arizona IncorporatedDistrict Court, D. Arizona · 2024